President and CEO.

Notably, the 0.10mg and 0.25mg doses of ADL5945 being tested in the PoC study were successfully evaluated in extended cohorts in the MAD research against...

Given that hes in his second and last term.

And why? Because employers can’t afford to spend Obamacare mandates and still stay competitive in the global industry. #10) Stepped-up attacks on veterans and preppersReturning...

Andrey Marchenko.

The intention-to-treat evaluation showed that there is no significant difference between your two trial groups with regards to the primary result, the death rate from...

Claire Harrison.

The EORTC QLQ-C30 includes five scales linked to working, nine scales related to symptoms, and a global health status and quality-of-life scale. The FACT-Lym includes...